NCT00348686 - Candesartan Effectiveness Study in Pro-B Type Natriuretic Peptides (BNP) | Biotech Hunter

Enrollment

315

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

HypertensionLeft Ventricular Hypertrophy

Interventions

DRUG

Candesartan

16 mg once daily in oral tablet form

DRUG

Candesartan

32 mg once daily in oral tablet form

DRUG

Felodipine

5 mg once daily in oral tablet form

DRUG

Felodipine

10 mg once daily in oral tablet form

Trial Locations (11)

Research Site, Busan

Research Site, Cheonan

Research Site, Cheongju-si

Research Site, Chunbuk

Research Site, Daegu

Research Site, Daejeon

Research Site, Gyungsangnamdo

Research Site, Jeonju

Research Site, Kwangju

Research Site, Pusan

Research Site, Ulsan